Clinical Trial Update: Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I) [Phase 1]

View source ↗

Summary

This Phase I trial evaluated the safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in adults and children, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Typhoid Fever

Drugs mentioned

• Vi-DT Typhoid Conjugate Vaccine (Vi-diphtheria toxoid conjugate vaccine)

Snippet

Sponsor: PT Bio Farma | Conditions: Safety Issues | Phase 1 | Status: COMPLETED